9 research outputs found
Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎ-Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π³Π΅Π½ΠΎΠ² ompA, ct135 ΠΈ tarP ΡΡΠ°ΠΌΠΌΠΎΠ² C. trachomatis, ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ ΠΎΡ Π±ΠΎΠ»ΡΠ½ΡΡ ΡΡΠΎΠ³Π΅Π½ΠΈΡΠ°Π»ΡΠ½ΠΎΠΉ Ρ Π»Π°ΠΌΠΈΠ΄ΠΈΠΈΠ½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠ΅ΠΉ
The article contains results of the molecular and genetic research of genes ompA, ct135 and tarp c. trachomatis in 50 samples of clinical material containing DNA c. trachomatis from patients (women and men) from the Moscow region with the diagnosed urogenital chlamydial infection (UGCI) confirmed by PCR method. The sequencing of the gene ompA allowed to establish, that the prevailing serovar c. trachomatis in the examined selection of UGCI patients was serovar Π (48,0%); other serovars were less often (G β 18,0%, D β 14,0%; F and J β by 8%, Π β 4%). The authors revealed authentic associations of the frequency of spreading of Π serovar with non-complicated clinical course of UGCI and the association of the frequency of spreading concerning rare serovars c. trachomatis (G, D, J) β with complications of UGCI in women. Significant mutations of the gene ompΠ in rare c. trachomatis serovars, Π°s well as significant mutations of genes ct135 and tarΡ were revealed more often is samples from women with PID. The obtained data are sufficient to make a conclusion about the possible existing relation between peculiarities of c. trachomatis genotype and the character of the clinical course of the urogenital clamidiosis.ΠΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Ρ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎ-Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π³Π΅Π½ΠΎΠ² ompA, ct135 ΠΈ tarP c. trachomatis Π² 50 ΠΎΠ±ΡΠ°Π·ΡΠ°Ρ
ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΌΠ°ΡΠ΅ΡΠΈΠ°Π»Π°, ΡΠΎΠ΄Π΅ΡΠΆΠ°Π²ΡΠΈΡ
ΠΠΠ c. trachomatis ΠΈ ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ
ΠΎΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² (ΠΆΠ΅Π½ΡΠΈΠ½ ΠΈ ΠΌΡΠΆΡΠΈΠ½) ΠΈΠ· ΠΠΎΡΠΊΠΎΠ²ΡΠΊΠΎΠ³ΠΎ ΡΠ΅Π³ΠΈΠΎΠ½Π° Ρ ΠΏΠΎΠ΄ΡΠ²Π΅ΡΠΆΠ΄Π΅Π½Π½ΡΠΌ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΠ¦Π Π΄ΠΈΠ°Π³Π½ΠΎΠ·ΠΎΠΌ ΡΡΠΎΠ³Π΅Π½ΠΈΡΠ°Π»ΡΠ½ΠΎΠΉ Ρ
Π»Π°ΠΌΠΈΠ΄ΠΈΠΉΠ½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ (Π£ΠΠ₯Π). Π ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ΅ ΡΠ΅ΠΊΠ²Π΅Π½ΠΈΡΠΎΠ²Π°Π½ΠΈΡ Π³Π΅Π½Π° ompA ΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΎ, ΡΡΠΎ ΠΏΡΠ΅ΠΎΠ±Π»Π°Π΄Π°ΡΡΠΈΠΌ ΡΠ΅ΡΠΎΠ²Π°ΡΠΎΠΌ c. trachomatis Π² ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½Π½ΠΎΠΉ Π²ΡΠ±ΠΎΡΠΊΠ΅ Π±ΠΎΠ»ΡΠ½ΡΡ
Π£ΠΠ₯Π ΡΠ²Π»ΡΠ»ΡΡ ΡΠ΅ΡΠΎΠ²Π°Ρ Π (48%); Π΄ΡΡΠ³ΠΈΠ΅ ΡΠ΅ΡΠΎΠ²Π°ΡΡ Π²ΡΡΡΠ΅ΡΠ°Π»ΠΈΡΡ Ρ ΠΌΠ΅Π½ΡΡΠ΅ΠΉ ΡΠ°ΡΡΠΎΡΠΎΠΉ (G β 18%, D β 14%; F ΠΈ J β ΠΏΠΎ 8%, Π β 4%). ΠΡΡΠ²Π»Π΅Π½Ρ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΡΠ΅ Π°ΡΡΠΎΡΠΈΠ°ΡΠΈΠΈ ΡΠ°ΡΡΠΎΡΡ ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½ΠΈΡ ΡΠ΅ΡΠΎΠ²Π°ΡΠ° Π Ρ Π½Π΅ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½Π½ΡΠΌ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ΠΌ Π£ΠΠ₯Π ΠΈ Π°ΡΡΠΎΡΠΈΠ°ΡΠΈΠΈ ΡΠ°ΡΡΠΎΡΡ ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½ΠΈΡ ΠΎΡΠ½ΠΎΡΠΈΡΠ΅Π»ΡΠ½ΠΎ ΡΠ΅Π΄ΠΊΠΎ Π²ΡΡΡΠ΅ΡΠ°ΡΡΠΈΡ
ΡΡ ΡΠ΅ΡΠΎΠ²Π°ΡΠΎΠ² c. trachomatis (G, D, J) β Ρ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΡΠΌΠΈ Π£ΠΠ₯Π Ρ ΠΆΠ΅Π½ΡΠΈΠ½. ΠΠ½Π°ΡΠΈΠΌΡΠ΅ ΠΌΡΡΠ°ΡΠΈΠΈ Π³Π΅Π½Π° ompΠ Π² ΡΠ΅Π΄ΠΊΠΎ Π²ΡΡΡΠ΅ΡΠ°ΡΡΠΈΡ
ΡΡ ΡΠ΅ΡΠΎΠ²Π°ΡΠ°Ρ
c. trachomatis, Π° ΡΠ°ΠΊΠΆΠ΅ Π·Π½Π°ΡΠΈΠΌΡΠ΅ ΠΌΡΡΠ°ΡΠΈΠΈ Π³Π΅Π½ΠΎΠ² ct135 ΠΈ tarP ΡΠ°ΡΠ΅ ΠΎΠ±Π½Π°ΡΡΠΆΠΈΠ²Π°Π»ΠΈΡΡ Π² ΠΎΠ±ΡΠ°Π·ΡΠ°Ρ
, ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ
ΠΎΡ ΠΆΠ΅Π½ΡΠΈΠ½ Ρ ΠΠΠΠΠ’. ΠΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ Π΄Π°Π½Π½ΡΠ΅ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΡΡ ΡΠ΄Π΅Π»Π°ΡΡ Π·Π°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅ ΠΎ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΠΌ ΡΡΡΠ΅ΡΡΠ²ΠΎΠ²Π°Π½ΠΈΠΈ Π²Π·Π°ΠΈΠΌΠΎΡΠ²ΡΠ·ΠΈ ΠΌΠ΅ΠΆΠ΄Ρ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΡΠΌΠΈ Π³Π΅Π½ΠΎΡΠΈΠΏΠ° c. trachomatis ΠΈ Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΎΠΌ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠ΅ΡΠ΅Π½ΠΈΡ ΡΡΠΎΠ³Π΅Π½ΠΈΡΠ°Π»ΡΠ½ΠΎΠ³ΠΎ Ρ
Π»Π°ΠΌΠΈΠ΄ΠΈΠΎΠ·Π°
ΠΠ΅Ρ Π°Π½ΠΈΠ·ΠΌΡ ΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΡΡΡΠΎΠΉΡΠΈΠ²ΠΎΡΡΠΈ Neisseria gonorrhoeae ΠΊ ΡΠ΅ΡΠ°Π»ΠΎΡΠΏΠΎΡΠΈΠ½Π°ΠΌ
The authors provide a review of the present-day literature data on the issues of studying the mechanisms of the formation of Neisseria gonorrhoeae resistance to third-generation cephalosporins. Studies in this field are needed in connection with the occurrence of strains resistant to third-generation cephalosporins as well as low-sensitivity strains. The authors emphasize the importance of mutations in porB, penA, mtrR, penB and ponA genes in the development of Neisseria gonorrhoeae resistance to Ξ²-lactam antibiotics and describe the prospects of studying the mosaic structure of the penA gene encoding the Π ΠΠ 2 protein as well as spatial structure of this protein.ΠΡΠΈΠ²Π΅Π΄Π΅Π½ ΠΎΠ±Π·ΠΎΡ ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΡ
Π΄Π°Π½Π½ΡΡ
Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ, ΠΏΠΎΡΠ²ΡΡΠ΅Π½Π½ΡΡ
Π²ΠΎΠΏΡΠΎΡΠ°ΠΌ ΠΈΠ·ΡΡΠ΅Π½ΠΈΡ ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΠΎΠ² ΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΠΎΡΡΠΈ Neisseria gonorrhoeae ΠΊ ΡΠ΅ΡΠ°Π»ΠΎΡΠΏΠΎΡΠΈΠ½Π°ΠΌ ΡΡΠ΅ΡΡΠ΅Π³ΠΎ ΠΏΠΎΠΊΠΎΠ»Π΅Π½ΠΈΡ. ΠΡΠΌΠ΅ΡΠ΅Π½Π° Π°ΠΊΡΡΠ°Π»ΡΠ½ΠΎΡΡΡ Π΄Π°Π½Π½ΠΎΠ³ΠΎ Π½Π°ΡΡΠ½ΠΎΠ³ΠΎ Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½ΠΈΡ Π² ΡΠ²ΡΠ·ΠΈ Ρ ΠΏΠΎΡΠ²Π»Π΅Π½ΠΈΠ΅ΠΌ ΡΡΠ°ΠΌΠΌΠΎΠ², ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΡΡ
ΠΊ ΡΠ΅ΡΠ°Π»ΠΎΡΠΏΠΎΡΠΈΠ½Π°ΠΌ ΡΡΠ΅ΡΡΠ΅Π³ΠΎ ΠΏΠΎΠΊΠΎΠ»Π΅Π½ΠΈΡ, ΠΈ ΡΡΠ°ΠΌΠΌΠΎΠ² ΡΠΎ ΡΠ½ΠΈΠΆΠ΅Π½Π½ΠΎΠΉ ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΡΡ. ΠΠΎΠΊΠ°Π·Π°Π½ΠΎ Π²Π°ΠΆΠ½ΠΎΠ΅ Π·Π½Π°ΡΠ΅Π½ΠΈΠ΅ Π² ΡΠ°Π·Π²ΠΈΡΠΈΠΈ ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΠΎΡΡΠΈ Neisseria gonorrhoeae ΠΊ Ξ²-Π»Π°ΠΊΡΠ°ΠΌΠ½ΡΠΌ Π°Π½ΡΠΈΠ±ΠΈΠΎΡΠΈΠΊΠ°ΠΌ ΠΌΡΡΠ°ΡΠΈΠΉ Π² Π³Π΅Π½Π°Ρ
porB, penA, mtrR, penB, ponA; ΠΎΡΠΌΠ΅ΡΠ΅Π½Π° ΠΏΠ΅ΡΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΠΈΠ·ΡΡΠ΅Π½ΠΈΡ ΠΌΠΎΠ·Π°ΠΈΡΠ½ΠΎΠΉ ΡΡΡΡΠΊΡΡΡΡ Π³Π΅Π½Π° penA, ΠΊΠΎΠ΄ΠΈΡΡΡΡΠ΅Π³ΠΎ Π±Π΅Π»ΠΎΠΊ Π ΠΠ 2, Π° ΡΠ°ΠΊΠΆΠ΅ ΠΏΡΠΎΡΡΡΠ°Π½ΡΡΠ²Π΅Π½Π½ΠΎΠΉ ΡΡΡΡΠΊΡΡΡΡ Π΄Π°Π½Π½ΠΎΠ³ΠΎ Π±Π΅Π»ΠΊΠ°
Π Π°Π·ΡΠ°Π±ΠΎΡΠΊΠ° ΠΏΡΠΎΡΠΎΠΊΠΎΠ»Π° ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎΠ³ΠΎΡΠΈΠΏΠΈΡΠΎΠ²Π°Π½ΠΈΡ C. Trachomatis Π½Π° ΠΎΡΠ½ΠΎΠ²Π΅ΡΠ΅ΠΊΠ²Π΅Π½ΠΈΡΠΎΠ²Π°Π½ΠΈΡ Π³Π΅Π½ΠΎΠ² ompa, pbpb, ct046, ct058,ct144, ct172
The article is devoted to the development and validation of a standard operating procedure entitled Β«Molecular typing
of Π‘. trachomatis for assessment of the clonal structure and extent of genetic diversity of Π‘. trachomatis strains
circulating in the territory of the Russian Federation.Β» The studies that involved the typing of C. trachomatis strains
obtained from regions of the Russian Federation with the use of six c. trachomatis genes (ompA, Π‘Π’046, cT058, cT144,
cT172 and pbpB) revealed their significant heterogenicity with the prevalence of the E serotype. However, the typing of
c. trachomatis for six genes at one time seems to be too time-consuming and long-lasting and is hard to be interpreted,
which explains the need to develop other typing protocols using a smaller number of relevant genes (not more than two
or three - by analogy with NG-MAST).Π‘ΡΠ°ΡΡΡ ΠΏΠΎΡΠ²ΡΡΠ΅Π½Π° ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠ΅ ΠΈ Π°ΠΏΡΠΎΠ±Π°ΡΠΈΠΈ ΡΡΠ°Π½Π΄Π°ΡΡΠ½ΠΎΠΉ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΉ ΠΏΡΠΎΡΠ΅Π΄ΡΡΡ Β«ΠΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎΠ΅ ΡΠΈΠΏΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅
Π‘.trachomatis Π΄Π»Ρ ΠΎΡΠ΅Π½ΠΊΠΈ ΠΊΠ»ΠΎΠ½Π°Π»ΡΠ½ΠΎΠΉ ΡΡΡΡΠΊΡΡΡΡ ΠΈ ΡΡΠ΅ΠΏΠ΅Π½ΠΈ Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠ°Π·Π½ΠΎΠΎΠ±ΡΠ°Π·ΠΈΡ ΡΡΠ°ΠΌΠΌΠΎΠ² Π‘.trachomatis,
ΡΠΈΡΠΊΡΠ»ΠΈΡΡΡΡΠΈΡ
Π½Π° ΡΠ΅ΡΡΠΈΡΠΎΡΠΈΠΈ Π ΠΎΡΡΠΈΠΉΡΠΊΠΎΠΉ Π€Π΅Π΄Π΅ΡΠ°ΡΠΈΠΈΒ». Π ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ΅ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½Π½ΡΡ
ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ ΠΏΠΎ ΡΠΈΠΏΠΈΡΠΎΠ²Π°Π½ΠΈΡ
ΡΡΠ°ΠΌΠΌΠΎΠ² c. trachomatis, ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ
ΠΈΠ· ΡΠ΅Π³ΠΈΠΎΠ½ΠΎΠ² Π ΠΎΡΡΠΈΠΉΡΠΊΠΎΠΉ Π€Π΅Π΄Π΅ΡΠ°ΡΠΈΠΈ Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ 6 Π³Π΅Π½ΠΎΠ² c. trachomatis
(ompA, Π‘Π’046, cT058, cT144, cT172 ΠΈ pbpB), Π±ΡΠ»Π° ΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½Π° ΠΈΡ
Π·Π½Π°ΡΠΈΡΠ΅Π»ΡΠ½Π°Ρ Π³Π΅ΡΠ΅ΡΠΎΠ³Π΅Π½Π½ΠΎΡΡΡ Ρ ΠΏΡΠ΅ΠΎΠ±Π»Π°Π΄Π°Π½ΠΈΠ΅ΠΌ
ΡΠ΅ΡΠΎΡΠΈΠΏΠ° Π. ΠΠ΄Π½Π°ΠΊΠΎ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠ΅ ΡΠΈΠΏΠΈΡΠΎΠ²Π°Π½ΠΈΡ c. trachomatis ΠΎΠ΄Π½ΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎ ΠΏΠΎ ΡΠ΅ΡΡΠΈ Π³Π΅Π½Π°ΠΌ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»ΡΠ΅ΡΡΡ ΠΈΠ·Π»ΠΈΡΠ½Π΅
ΡΡΡΠ΄ΠΎΠ΅ΠΌΠΊΠΈΠΌ, Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΡΠΌ Π²ΠΎ Π²ΡΠ΅ΠΌΠ΅Π½ΠΈ, ΡΡΡΠ΄Π½ΠΎ ΠΈΠ½ΡΠ΅ΡΠΏΡΠ΅ΡΠΈΡΡΠ΅ΠΌΡΠΌ, ΡΡΠΎ ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ΅Ρ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΡΡΡ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠΈ
Π΄ΡΡΠ³ΠΈΡ
ΠΡΠΎΡΠΎΠΊΠΎΠ»ΠΎΠ² ΡΠΈΠΏΠΈΡΠΎΠ²Π°Π½ΠΈΡ Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΠΌΠ΅Π½ΡΡΠ΅Π³ΠΎ ΡΠΈΡΠ»Π° (Π½Π΅ Π±ΠΎΠ»Π΅Π΅ 2-3 - ΠΏΠΎ Π°Π½Π°Π»ΠΎΠ³ΠΈΠΈ Ρ NG-MAST)
Π·Π½Π°ΡΠΈΠΌΡΡ
Π³Π΅Π½ΠΎΠ²
Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΈΠ·ΡΡΠ΅Π½ΠΈΡ Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΠΏΡΠ΅Π΄ΡΠ°ΡΠΏΠΎΠ»ΠΎΠΆΠ΅Π½Π½ΠΎΡΡΠΈ ΠΊ ΠΏΡΠΎΡΠΈΠ°Π·Ρ ΡΡΠ΅Π΄ΠΈ Π½Π°ΡΠ΅Π»Π΅Π½ΠΈΡ Π ΠΎΡΡΠΈΠΉΡΠΊΠΎΠΉ Π€Π΅Π΄Π΅ΡΠ°ΡΠΈΠΈ
Goal. To assess the incidence of genes predisposing to the development of psoriasis based on selected molecular and genetic study methods among the Russian population. Materials and methods. By using allele specific hybridization methods in the form of real-time PCR and RFLP assay (Restriction Fragment Length Polymorphism), single-nucleotide polymorphisms of fragments of 13 genes associated with predisposition to the development of psoriasis were studied in whole blood samples obtained from 45 psoriatic patients: rs4649203 (gene IL-28RA), rs11209026 (gene IL-23R), rs610604 (gene TNFAIP3), rs514315 (gene SERPINB8), rs9304742 (gene ZNF816A), rs17728338 (gene TNIP1), rs13190932 (gene TRAF3IP2), rs2235617 (gene ZNF313), rs27524 (gene ERAP1), rs702873 (gene REL), rs3213094 (gene IL-12B), rs12720356 (gene TYK2), and rs8016947 (gene NFKBI). Results. A set of data on the genotype structure and incidence in respective loci of 13 genes associated with predisposition to develop psoriasis was obtained for the first time based on a Russian sample of patients. At this stage of the study, we failed to reveal any reliable differences concerning the incidence of individual genotypes between psoriatic patients and healthy people because of the small size of the sample. Gene TYK2 (rs1272035) served as an exclusion. The homozygous T/T genotype was revealed more often (p < 0.01) in psoriatic patients (95.6%) vs. healthy people (77.8%), which makes it possible to consider the carriers of this genotype as people predisposed to the development of psoriasis.Π¦Π΅Π»Ρ. ΠΡΠ΅Π½ΠΊΠ° ΡΠ°ΡΡΠΎΡΡ Π²ΡΡΡΠ΅ΡΠ°Π΅ΠΌΠΎΡΡΠΈ Π² ΡΠΎΡΡΠΈΠΉΡΠΊΠΎΠΉ ΠΏΠΎΠΏΡΠ»ΡΡΠΈΠΈ Π³Π΅Π½ΠΎΠ² ΠΏΡΠ΅Π΄ΡΠ°ΡΠΏΠΎΠ»ΠΎΠΆΠ΅Π½Π½ΠΎΡΡΠΈ ΠΊ ΠΏΡΠΎΡΠΈΠ°Π·Ρ Π²ΡΠ±ΡΠ°Π½Π½ΡΠΌΠΈ ΠΌΠ΅ΡΠΎΠ΄Π°ΠΌΠΈ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎ-Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ. ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΠ΅ΡΠΎΠ΄Π°ΠΌΠΈ Π°Π»Π»Π΅Π»Ρ-ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ Π³ΠΈΠ±ΡΠΈΠ΄ΠΈΠ·Π°ΡΠΈΠΈ Π² ΡΠΎΡΠΌΠ°ΡΠ΅ ΠΠ¦Π Π² ΡΠ΅Π°Π»ΡΠ½ΠΎΠΌ Π²ΡΠ΅ΠΌΠ΅Π½ΠΈ ΠΈ ΠΠΠ Ρ-Π°Π½Π°Π»ΠΈΠ·Π° (Π°Π½Π°Π»ΠΈΠ· ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠΈΠ·ΠΌΠ° Π΄Π»ΠΈΠ½Ρ ΡΠ΅ΡΡΡΠΈΠΊΡΠΈΠΎΠ½Π½ΡΡ
ΡΡΠ°Π³ΠΌΠ΅Π½ΡΠΎΠ²) Π² ΠΎΠ±ΡΠ°Π·ΡΠ°Ρ
ΡΠ΅Π»ΡΠ½ΠΎΠΉ ΠΊΡΠΎΠ²ΠΈ, ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ
ΠΎΡ 45 Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΏΡΠΎΡΠΈΠ°Π·ΠΎΠΌ, Π±ΡΠ»ΠΈ ΠΈΠ·ΡΡΠ΅Π½Ρ ΠΎΠ΄Π½ΠΎΠ½ΡΠΊΠ»Π΅ΠΎΡΠΈΠ΄Π½ΡΠ΅ ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠΈΠ·ΠΌΡ ΡΡΠ°Π³ΠΌΠ΅Π½ΡΠΎΠ² 13-ΠΈ Π³Π΅Π½ΠΎΠ², Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
Ρ ΠΏΡΠ΅Π΄ΡΠ°ΡΠΏΠΎΠ»ΠΎΠΆΠ΅Π½Π½ΠΎΡΡΡΡ ΠΊ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΏΡΠΎΡΠΈΠ°Π·Π°: rs4649203 (Π³Π΅Π½ IL-28RA), rs11209026 (Π³Π΅Π½ IL-23R), rs610604 (Π³Π΅Π½ TNFAIP3), rs514315 (Π³Π΅Π½ SERPINB8), rs9304742 (Π³Π΅Π½ ZNF816A), rs17728338 (Π³Π΅Π½ TNIP1), rs13190932 (Π³Π΅Π½ TRAF3IP2), rs2235617 (Π³Π΅Π½ ZNF313), rs27524 (Π³Π΅Π½ ERAP1), rs702873 (Π³Π΅Π½ REL), rs3213094 (Π³Π΅Π½ IL-12B), rs12720356 (Π³Π΅Π½ TYK2), rs8016947 (Π³Π΅Π½ NFKBI). Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΠΏΠ΅ΡΠ²ΡΠ΅ Π½Π° ΡΠΎΡΡΠΈΠΉΡΠΊΠΎΠΉ Π²ΡΠ±ΠΎΡΠΊΠ΅ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΠΏΠΎΠ»ΡΡΠ΅Π½ ΠΌΠ°ΡΡΠΈΠ² Π΄Π°Π½Π½ΡΡ
ΠΎ ΡΡΡΡΠΊΡΡΡΠ΅ ΠΈ ΡΠ°ΡΡΠΎΡΠ΅ Π²ΡΡΡΠ΅ΡΠ°Π΅ΠΌΠΎΡΡΠΈ Π³Π΅Π½ΠΎΡΠΈΠΏΠΎΠ² Π² ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²ΡΡΡΠΈΡ
ΠΏΠΎΠ·ΠΈΡΠΈΡΡ
13 Π³Π΅Π½ΠΎΠ², Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
Ρ ΠΏΡΠ΅Π΄ΡΠ°ΡΠΏΠΎΠ»ΠΎΠΆΠ΅Π½Π½ΠΎΡΡΡΡ ΠΊ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΏΡΠΎΡΠΈΠ°Π·Π°. ΠΠ° Π΄Π°Π½Π½ΠΎΠΌ ΡΡΠ°ΠΏΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΡΡ
ΠΎΡΠ»ΠΈΡΠΈΠΉ Π² ΡΠ°ΡΡΠΎΡΠ΅ Π²ΡΡΡΠ΅ΡΠ°Π΅ΠΌΠΎΡΡΠΈ ΠΎΡΠ΄Π΅Π»ΡΠ½ΡΡ
Π³Π΅Π½ΠΎΡΠΈΠΏΠΎΠ² ΠΌΠ΅ΠΆΠ΄Ρ Π±ΠΎΠ»ΡΠ½ΡΠΌΠΈ ΠΏΡΠΎΡΠΈΠ°Π·ΠΎΠΌ ΠΈ Π·Π΄ΠΎΡΠΎΠ²ΡΠΌΠΈ Π²ΡΡΠ²Π»Π΅Π½ΠΎ Π½Π΅ Π±ΡΠ»ΠΎ Π²Π²ΠΈΠ΄Ρ ΠΎΡΠ½ΠΎΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΠΌΠ°Π»ΠΎΡΠΈΡΠ»Π΅Π½Π½ΠΎΡΡΠΈ Π²ΡΠ±ΠΎΡΠΊΠΈ. ΠΡΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅ ΡΠΎΡΡΠ°Π²ΠΈΠ» Π³Π΅Π½ TYK2 (rs1272035). ΠΠΎΠΌΠΎΠ·ΠΈΠ³ΠΎΡΠ½ΡΠΉ Π’/Π’ Π³Π΅Π½ΠΎΡΠΈΠΏ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ ΡΠ°ΡΠ΅ (Ρ < 0,01) Π²ΡΡΡΠ΅ΡΠ°Π»ΡΡ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΏΡΠΎΡΠΈΠ°Π·ΠΎΠΌ (95,6%) Π² ΡΡΠ°Π²Π½Π΅Π½ΠΈΠΈ ΡΠΎ Π·Π΄ΠΎΡΠΎΠ²ΡΠΌΠΈ (77,8%), ΡΡΠΎ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ΅Ρ ΡΠ°ΡΡΠΌΠ°ΡΡΠΈΠ²Π°ΡΡ Π½ΠΎΡΠΈΡΠ΅Π»Π΅ΠΉ Π΄Π°Π½Π½ΠΎΠ³ΠΎ Π³Π΅Π½ΠΎΡΠΈΠΏΠ° ΠΊΠ°ΠΊ Π»ΠΈΡ Ρ ΠΏΡΠ΅Π΄ΡΠ°ΡΠΏΠΎΠ»ΠΎΠΆΠ΅Π½Π½ΠΎΡΡΡΡ ΠΊ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΏΡΠΎΡΠΈΠ°Π·Π°
Π ΠΎΠ»Ρ ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠΈΠ·ΠΌΠΎΠ² Π³Π΅Π½Π° PERP Π² ΡΠ°Π·Π²ΠΈΡΠΈΠΈ Π°ΠΊΠ°Π½ΡΠΎΠ»ΠΈΠ·Π° Ρ Π±ΠΎΠ»ΡΠ½ΡΡ ΠΈΡΡΠΈΠ½Π½ΠΎΠΉ Π°ΠΊΠ°Π½ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΎΠΉ
Goal. To determine the nucleotide protein-coding PERP gene sequence and assess the relation between the revealed mutations/polymorphisms and development of true acantholytic pemphigus as well as particular features of its course. Materials and methods. The protein-coding PERP gene DNA sequence was studied by the sequence analysis method in 18 patients with true acantholytic pemphigus. Results. Two polymorphisms were discovered in patients with true acantholytic pemphigus in Exon 3 of the PERP gene for the first time: rs648802 (non-synonymous) and rs648396 (synonymous). The incidence of wild type genotypes in the revealed polymorphisms (Π‘/Π‘ genotype rs648802 and Π’/Π’ genotype rs648396) in healthy volunteers reliably exceeded that in patients (p = 0.049). Patients with true acantholytic pemphigus are characterized by a higher incidence rate of mutant heterozygous genotypes Π‘/G rs648802 and Π’/C rs648396 (p = 0.09). Mutant heterozygous genotypes of the polymorphisms (G/G genotype rs648802 and Π‘/Π‘ genotype rs648396) were revealed in patients with the earlier onset of the disease (41-60 years) (p = 0.025) more often while heterozygous genotypes (Π‘/G genotype rs648802 and T/Π‘ genotype rs648396) were revealed when the disease developed at the age of 61 or older more often (p = 0.01). Conclusion. Identification of the polymorphous genotype by the sequence method or other molecular methods (e.g. PCR) can be used to forecast the terms when true acantholytic pemphigus can emerge in genetically inclined patients. However, it should be noted that it is necessary to specify the preliminary results obtained based on a greater sample of patients with true acantholytic pemphigus.Π¦Π΅Π»Ρ. ΠΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ Π½ΡΠΊΠ»Π΅ΠΎΡΠΈΠ΄Π½ΠΎΠΉ Π±Π΅Π»ΠΎΠΊ-ΠΊΠΎΠ΄ΠΈΡΡΡΡΠ΅ΠΉ ΠΏΠΎΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ Π³Π΅Π½Π° PERP Ρ ΠΎΡΠ΅Π½ΠΊΠΎΠΉ Π²Π·Π°ΠΈΠΌΠΎΡΠ²ΡΠ·ΠΈ ΠΌΠ΅ΠΆΠ΄Ρ Π²ΡΡΠ²Π»Π΅Π½Π½ΡΠΌΠΈ ΠΌΡΡΠ°ΡΠΈΡΠΌΠΈ/ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠΈΠ·ΠΌΠ°ΠΌΠΈ ΠΈ ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ΠΌ ΠΈΡΡΠΈΠ½Π½ΠΎΠΉ Π°ΠΊΠ°Π½ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΈ, ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΡΠΌΠΈ Π΅Π΅ ΡΠ΅ΡΠ΅Π½ΠΈΡ. ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΠ΅ΡΠΎΠ΄ΠΎΠΌ ΡΠ΅ΠΊΠ²Π΅Π½ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½Π° Π±Π΅Π»ΠΎΠΊ-ΠΊΠΎΠ΄ΠΈΡΡΡΡΠ°Ρ ΠΏΠΎΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΠ½ΠΎΡΡΡ ΠΠΠ Π³Π΅Π½Π° PERP Ρ 18 Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΈΡΡΠΈΠ½Π½ΠΎΠΉ Π°ΠΊΠ°Π½ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΎΠΉ. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΠΏΠ΅ΡΠ²ΡΠ΅ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΈΡΡΠΈΠ½Π½ΠΎΠΉ Π°ΠΊΠ°Π½ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΎΠΉ Π² 3-ΠΌ ΡΠΊΠ·ΠΎΠ½Π΅ Π³Π΅Π½Π° PERP Π±ΡΠ»ΠΈ Π²ΡΡΠ²Π»Π΅Π½Ρ Π΄Π²Π° ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠΈΠ·ΠΌΠ°: rs648802 (Π½Π΅ΡΠΈΠ½ΠΎΠ½ΠΈΠΌΠΈΡΠ½ΡΠΉ) ΠΈ rs648396 (ΡΠΈΠ½ΠΎΠ½ΠΈΠΌΠΈΡΠ½ΡΠΉ). Π§Π°ΡΡΠΎΡΠ° Π²ΡΡΡΠ΅ΡΠ°Π΅ΠΌΠΎΡΡΠΈ Π³Π΅Π½ΠΎΡΠΈΠΏΠΎΠ² Β«Π΄ΠΈΠΊΠΎΠ³ΠΎΒ» ΡΠΈΠΏΠ° Π²ΡΡΠ²Π»Π΅Π½Π½ΡΡ
ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠΈΠ·ΠΌΠΎΠ² (Π‘/Π‘ Π³Π΅Π½ΠΎΡΠΈΠΏ rs648802 ΠΈ Π’/Π’ Π³Π΅Π½ΠΎΡΠΈΠΏ rs648396) Ρ Π·Π΄ΠΎΡΠΎΠ²ΡΡ
Π΄ΠΎΠ±ΡΠΎΠ²ΠΎΠ»ΡΡΠ΅Π² Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ ΠΏΡΠ΅Π²ΡΡΠΈΠ»Π° ΡΠ°ΡΡΠΎΡΡ Π²ΡΡΡΠ΅ΡΠ°Π΅ΠΌΠΎΡΡΠΈ Π΄Π°Π½Π½ΡΡ
Π³Π΅Π½ΠΎΡΠΈΠΏΠΎΠ² Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
(Ρ = 0,049). Π£ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΈΡΡΠΈΠ½Π½ΠΎΠΉ Π°ΠΊΠ°Π½ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΎΠΉ ΠΎΡΠΌΠ΅ΡΠ΅Π½Π° ΡΠ΅Π½Π΄Π΅Π½ΡΠΈΡ ΠΊ Π±ΠΎΠ»Π΅Π΅ ΡΠ°ΡΡΠΎΠΌΡ Π²ΡΡΠ²Π»Π΅Π½ΠΈΡ ΠΌΡΡΠ°Π½ΡΠ½ΡΡ
Π³Π΅ΡΠ΅ΡΠΎΠ·ΠΈΠ³ΠΎΡΠ½ΡΡ
Π³Π΅Π½ΠΎΡΠΈΠΏΠΎΠ² Π‘/G rs648802 ΠΈ Π’/C rs648396 (Ρ = 0,09). ΠΡΡΠ°Π½ΡΠ½ΡΠ΅ Π³ΠΎΠΌΠΎΠ·ΠΈΠ³ΠΎΡΠ½ΡΠ΅ Π³Π΅Π½ΠΎΡΠΈΠΏΡ Π΄Π°Π½Π½ΡΡ
ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠΈΠ·ΠΌΠΎΠ² (G/G Π³Π΅Π½ΠΎΡΠΈΠΏ rs648802 ΠΈ Π‘/Π‘ Π³Π΅Π½ΠΎΡΠΈΠΏ rs648396) ΡΠ°ΡΠ΅ Π²ΡΡΠ²Π»ΡΠ»ΠΈΡΡ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ Π±ΠΎΠ»Π΅Π΅ ΡΠ°Π½Π½ΠΈΠΌ Π½Π°ΡΠ°Π»ΠΎΠΌ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ (41-60 Π»Π΅Ρ) (Ρ = 0,025), Π° Π³Π΅ΡΠ΅ΡΠΎΠ·ΠΈΠ³ΠΎΡΠ½ΡΠ΅ Π³Π΅Π½ΠΎΡΠΈΠΏΡ (Π‘/G Π³Π΅Π½ΠΎΡΠΈΠΏ rs648802 ΠΈ T/Π‘ Π³Π΅Π½ΠΎΡΠΈΠΏ rs648396) ΡΠ°ΡΠ΅ ΠΎΠ±Π½Π°ΡΡΠΆΠΈΠ²Π°Π»ΠΈΡΡ ΠΏΡΠΈ ΠΌΠ°Π½ΠΈΡΠ΅ΡΡΠ°ΡΠΈΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ Π² Π²ΠΎΠ·ΡΠ°ΡΡΠ΅ 61 Π³ΠΎΠ΄Π° ΠΈ ΡΡΠ°ΡΡΠ΅ (Ρ = 0,01). ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΠ΄Π΅Π½ΡΠΈΡΠΈΠΊΠ°ΡΠΈΡ ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠ½ΠΎΠ³ΠΎ Π³Π΅Π½ΠΎΡΠΈΠΏΠ° ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΡΠ΅ΠΊΠ²Π΅Π½ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΈΠ»ΠΈ Π΄ΡΡΠ³ΠΈΠΌΠΈ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΡΠΌΠΈ ΠΌΠ΅ΡΠΎΠ΄Π°ΠΌΠΈ (Π½Π°ΠΏΡΠΈΠΌΠ΅Ρ ΠΠ¦Π -ΠΠ€Π Π€) ΠΌΠΎΠΆΠ΅Ρ Π±ΡΡΡ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½Π° Ρ ΡΠ΅Π»ΡΡ ΠΏΡΠΎΠ³Π½ΠΎΠ·ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΡΡΠΎΠΊΠΎΠ² ΠΌΠ°Π½ΠΈΡΠ΅ΡΡΠ°ΡΠΈΠΈ ΠΈΡΡΠΈΠ½Π½ΠΎΠΉ Π°ΠΊΠ°Π½ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΈ Ρ Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈ ΠΏΡΠ΅Π΄ΡΠ°ΡΠΏΠΎΠ»ΠΎΠΆΠ΅Π½Π½ΡΡ
ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ². ΠΠ΄Π½Π°ΠΊΠΎ ΡΠ»Π΅Π΄ΡΠ΅Ρ ΠΏΠΎΠ΄ΡΠ΅ΡΠΊΠ½ΡΡΡ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΡΡΡ ΡΡΠΎΡΠ½Π΅Π½ΠΈΡ ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ
ΠΏΡΠ΅Π΄Π²Π°ΡΠΈΡΠ΅Π»ΡΠ½ΡΡ
ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² Π½Π° Π±ΠΎΠ»Π΅Π΅ ΠΊΡΡΠΏΠ½ΠΎΠΉ Π²ΡΠ±ΠΎΡΠΊΠ΅ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΈΡΡΠΈΠ½Π½ΠΎΠΉ Π°ΠΊΠ°Π½ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ·ΡΡΡΠ°ΡΠΊΠΎΠΉ
ΠΡΡΠΎΡΠΈΠ°ΡΠΈΡ ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠΈΠ·ΠΌΠΎΠ² Π² Π³Π΅Π½Π°Ρ TNFAIP3 ΠΈ TNIPI Ρ ΠΏΡΠ΅Π΄ΡΠ°ΡΠΏΠΎΠ»ΠΎΠΆΠ΅Π½Π½ΠΎΡΡΡΡ ΠΊ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΏΡΠΎΡΠΈΠ°Π·Π° Π² ΡΠΎΡΡΠΈΠΉΡΠΊΠΎΠΉ ΠΏΠΎΠΏΡΠ»ΡΡΠΈΠΈ
Goal. To study polymorphisms in TNFAIP3 (rs610604) and TNIPI (rs17728338) genes in a sample of psoriasis patients and healthy volunteers from the Russian Federation. Materials and methods. By using allele specific hybridization methods in the form of real-time PCR and RFLP assay (Restriction Fragment Length Polymorphism), single-nucleotide polymorphisms of fragments of the following genes associated with predisposition to the development of psoriasis were studied in whole blood samples taken from psoriasis patients (n = 286) and healthy volunteers (n = 89): TNFAIP3 (rs610604) and TNIPI (rs17728338). Results. Psoriasis patients had a reliable increase in the frequency of the A/C heterozygous genotype of rs610604 polymorphism of the TNFAIP3 gene and A allele of rs17728338 polymorphism of the TNIP1 gene (A/G and A/A genotypes), which makes it possible to treat carriers of these genotypes as people with predisposition to the development of psoriasis, and to treat A/C genotypes of rs610604 polymorphism and A/G and A/A genotypes of rs17728338 polymorphism as predictors of the development of psoriasis in the Russian population. Conclusion. these data broaden the perception of genetic factors associated with the development of psoriasis in persons from the Russian population.Π¦Π΅Π»Ρ. ΠΠ·ΡΡΠΈΡΡ ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠΈΠ·ΠΌΡ Π³Π΅Π½ΠΎΠ² TNFAIP3 (rs610604) ΠΈ TNIPI (rs17728338) Π² Π²ΡΠ±ΠΎΡΠΊΠ΅ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΏΡΠΎΡΠΈΠ°Π·ΠΎΠΌ ΠΈ Π·Π΄ΠΎΡΠΎΠ²ΡΡ
Π΄ΠΎΠ±ΡΠΎΠ²ΠΎΠ»ΡΡΠ΅Π² ΠΈΠ· Π ΠΎΡΡΠΈΠΉΡΠΊΠΎΠΉ Π€Π΅Π΄Π΅ΡΠ°ΡΠΈΠΈ. ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΠ΅ΡΠΎΠ΄Π°ΠΌΠΈ Π°Π»Π»Π΅Π»ΡΡΠΏΠ΅ΡΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ Π³ΠΈΠ±ΡΠΈΠ΄ΠΈΠ·Π°ΡΠΈΠΈ Π² ΡΠΎΡΠΌΠ°ΡΠ΅ ΠΠ¦Π Π² ΡΠ΅Π°Π»ΡΠ½ΠΎΠΌ Π²ΡΠ΅ΠΌΠ΅Π½ΠΈ ΠΈ ΠΠΠ Π€-Π°Π½Π°Π»ΠΈΠ·Π° (Π°Π½Π°Π»ΠΈΠ· ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠΈΠ·ΠΌΠ° Π΄Π»ΠΈΠ½Ρ ΡΠ΅ΡΡΡΠΈΠΊΡΠΈΠΎΠ½Π½ΡΡ
ΡΡΠ°Π³ΠΌΠ΅Π½ΡΠΎΠ²) Π² ΠΎΠ±ΡΠ°Π·ΡΠ°Ρ
ΡΠ΅Π»ΡΠ½ΠΎΠΉ ΠΊΡΠΎΠ²ΠΈ, ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ
ΠΎΡ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΏΡΠΎΡΠΈΠ°Π·ΠΎΠΌ (n = 286) ΠΈ Π·Π΄ΠΎΡΠΎΠ²ΡΡ
Π΄ΠΎΠ±ΡΠΎΠ²ΠΎΠ»ΡΡΠ΅Π² (n = 89), Π±ΡΠ»ΠΈ ΠΈΠ·ΡΡΠ΅Π½Ρ ΠΎΠ΄Π½ΠΎΠ½ΡΠΊΠ»Π΅ΠΎΡΠΈΠ΄Π½ΡΠ΅ ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠΈΠ·ΠΌΡ ΡΡΠ°Π³ΠΌΠ΅Π½ΡΠΎΠ² Π³Π΅Π½ΠΎΠ², Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
Ρ ΠΏΡΠ΅Π΄ΡΠ°ΡΠΏΠΎΠ»ΠΎΠΆΠ΅Π½Π½ΠΎΡΡΡΡ ΠΊ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΏΡΠΎΡΠΈΠ°Π·Π°: TNFAIP3 (rs610604) ΠΈ TNIPI (rs17728338). Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΏΡΠΎΡΠΈΠ°Π·ΠΎΠΌ ΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΎ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎΠ΅ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠ΅ ΡΠ°ΡΡΠΎΡΡ Π²ΡΡΡΠ΅ΡΠ°Π΅ΠΌΠΎΡΡΠΈ Π³Π΅ΡΠ΅ΡΠΎΠ·ΠΈΠ³ΠΎΡΠ½ΠΎΠ³ΠΎ Π³Π΅Π½ΠΎΡΠΈΠΏΠ° A/C ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠΈΠ·ΠΌΠ° rs610604, Π³Π΅Π½Π° TNFAIP3 ΠΈ Π°Π»Π»Π΅Π»Ρ Π ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠΈΠ·ΠΌΠ° rs17728338 Π³Π΅Π½Π° TNIP1 (Π³Π΅Π½ΠΎΡΠΈΠΏΡ A/G ΠΈ A/A), ΡΡΠΎ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ΅Ρ ΡΠ°ΡΡΠΌΠ°ΡΡΠΈΠ²Π°ΡΡ Π½ΠΎΡΠΈΡΠ΅Π»Π΅ΠΉ Π΄Π°Π½Π½ΡΡ
Π³Π΅Π½ΠΎΡΠΈΠΏΠΎΠ² ΠΊΠ°ΠΊ Π»ΠΈΡ Ρ ΠΏΡΠ΅Π΄ΡΠ°ΡΠΏΠΎΠ»ΠΎΠΆΠ΅Π½Π½ΠΎΡΡΡΡ ΠΊ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΏΡΠΎΡΠΈΠ°Π·Π°, Π° Π³Π΅Π½ΠΎΡΠΈΠΏΡ A/Π‘ ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠΈΠ·ΠΌΠ° rs610604, A/G ΠΈ A/A ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠΈΠ·ΠΌΠ° rs17728338 β ΠΊΠ°ΠΊ ΠΏΡΠ΅Π΄ΠΈΠΊΡΠΎΡΡ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΏΡΠΎΡΠΈΠ°Π·Π° Π² ΡΠΎΡΡΠΈΠΉΡΠΊΠΎΠΉ ΠΏΠΎΠΏΡΠ»ΡΡΠΈΠΈ. ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ Π΄Π°Π½Π½ΡΠ΅ ΡΠ°ΡΡΠΈΡΡΡΡ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ΠΈΡ ΠΎ Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ°ΠΊΡΠΎΡΠ°Ρ
, Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
Ρ ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ΠΌ ΠΏΡΠΎΡΠΈΠ°Π·Π°, Ρ Π»ΠΈΡ ΠΈΠ· ΡΠΎΡΡΠΈΠΉΡΠΊΠΎΠΉ ΠΏΠΎΠΏΡΠ»ΡΡΠΈΠΈ